Cibus, Inc.

Healthcare

NASDAQ:CBUS · NASDAQ Capital Market

Market Cap $55.95M Beta 1.65 P/E (TTM) -7.9

$1.31 -1.60%

-$0.02 today

52W Low $1.09High $4.19

Vol 0.11M · Avg 0.52M

EPS (TTM) -$0.16Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-9.66%

Period High

$4.05

Period Low

$1.16

Latest

$1.31

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relmada Therapeutics, Inc.

NASDAQ:RLMD

$487.67M

Unicycive Therapeutics, Inc.

NASDAQ:UNCY

$155.81M

Immunic, Inc.

NASDAQ:IMUX

$136.78M

Vaxart, Inc.

NASDAQ:VXRT

$135.55M

Repare Therapeutics Inc.

RPTX

$114.24M

CAMP4 Therapeutics Corporation

NASDAQ:CAMP

$89.00M

Biomea Fusion, Inc.

NASDAQ:BMEA

$69.61M

MediciNova, Inc.

NASDAQ:MNOV

$60.54M

PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

$59.20M

Acrivon Therapeutics, Inc. Common Stock

ACRV

$46.70M

What is the latest CBUS filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does CBUS have?

Intrinsic Alpha currently shows 20 recent filings for CBUS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.